Cohen Klingenstein’s Organon & Co OGN Stock Holding History

Cohen Klingenstein’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,429	Closed	-$196K	–	223
2024 Q1	$196K	Hold	10,429	–	–	0.01%	222
2023 Q4	$150K	Sell	10,429 -2,636	-20%	-$35.9K	0.01%	222
2023 Q3	$227K	Sell	13,065 -1,924	-13%	-$40.1K	0.01%	217
2023 Q2	$312K	Hold	14,989	–	–	0.01%	209
2023 Q1	$353K	Hold	14,989	–	–	0.02%	204
2022 Q4	$419K	Sell	14,989 -308	-2%	-$7.88K	0.02%	194
2022 Q3	$358K	Sell	15,297 -400	-3%	-$12.1K	0.02%	200
2022 Q2	$530K	Hold	15,697	–	–	0.03%	192
2022 Q1	$548K	Hold	15,697	–	–	0.02%	192
2021 Q4	$478K	Sell	15,697 -2,316	-13%	-$75.4K	0.02%	201
2021 Q3	$591K	Sell	18,013 -2,467	-12%	-$78.9K	0.03%	207
2021 Q2	$620K	Buy	+20,480	New	+$674K	0.03%	202

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cohen Klingenstein's OGN Position: Q2 2024 in Review

Cohen Klingenstein sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 10,429 shares — an estimated $196K sold.

Cohen Klingenstein first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $620K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

Cohen Klingenstein reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
Cohen Klingenstein sold 10,429 Organon & Co shares in Q2 2024, an estimated $196K.
Cohen Klingenstein first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
Cohen Klingenstein's Organon & Co position peaked at $620K in Q2 2021.
724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Cohen Klingenstein's 13F filing for Q2 2024, filed 15 Jul 2024.